Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 757

1.

IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes.

de Melo Campos P, Machado-Neto JA, Lorand-Metze I, Costa FF, Olalla Saad ST, Traina F.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):92-95. doi: 10.1016/j.bjhh.2017.10.001. Epub 2017 Nov 28. No abstract available.

2.

Bleomycin induced hyperpigmentation of skin.

Mishra K, Jandial A, Prakash G.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):90-91. doi: 10.1016/j.bjhh.2017.08.005. Epub 2017 Nov 24. No abstract available.

3.

Compound heterozygote of Hb DIran [HBB: c.67G>C, β 22(B4) Glu>Gln] with β0-thalassemia [cds 41/42 (-CTTT)] from Eastern India.

Mohanty PK, Meher S, Dehury S, Bhattacharya S, Das K, Patel S, Sarkar B.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):82-85. doi: 10.1016/j.bjhh.2017.09.001. Epub 2017 Dec 1. No abstract available.

4.

Novel mutations associated with pyruvate kinase deficiency in Brazil.

Svidnicki MCCM, Santos A, Fernandez JAA, Yokoyama APH, Magalhães IQ, Pinheiro VRP, Brandalise SR, Silveira PAA, Costa FF, Saad STO.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):5-11. doi: 10.1016/j.bjhh.2017.08.007. Epub 2017 Nov 26.

5.

Can dentists detect multiple myeloma through oral manifestations?

Almeida TMX, Cavalcanti ÉFF, Freitas ADS, Magalhães RJP, Maiolino A, Torres SR.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):43-49. doi: 10.1016/j.bjhh.2017.08.006. Epub 2017 Nov 24.

6.

Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil.

Lobo CLC, Nascimento EMD, Jesus LJC, Freitas TG, Lugon JR, Ballas SK.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):37-42. doi: 10.1016/j.bjhh.2017.09.006. Epub 2017 Dec 6.

7.

Multiple myeloma and central nervous system involvement: experience of a Brazilian center.

Dias ALMS, Higashi F, Peres ALM, Cury P, Crusoé EQ, Hungria VTM.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):30-36. doi: 10.1016/j.bjhh.2017.09.004. Epub 2017 Nov 26.

8.

The interpretation of rare or novel variants: damaging vs. disease-causing.

Gutierrez-Rodrigues F, Calado RT.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):3-4. doi: 10.1016/j.bjhh.2017.10.003. Epub 2017 Dec 6. No abstract available.

9.

Transfusion management for patients taking an anti-CD38 monoclonal antibody.

Bub CB, Reis IND, Aravechia MG, Santos LD, Bastos EP, Kutner JM, Castilho L.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):25-29. doi: 10.1016/j.bjhh.2017.09.003. Epub 2017 Nov 26.

10.

Validation of the Brazilian version of the VERITAS-Pro scale to assess adherence to prophylactic regimens in hemophilia.

Ferreira AA, Leite ICG, Duncan NA.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):18-24. doi: 10.1016/j.bjhh.2017.09.002. Epub 2017 Nov 26.

11.

Platelet count response to Helicobacter pylori eradication for idiopathic thrombocytopenic purpura in northeastern Brazil.

Barbosa AMC, Ribeiro RA, Silva CÍSM, Cruz FWS, Azevedo OGR, Pitombeira MHDS, Braga LLC.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):12-17. doi: 10.1016/j.bjhh.2017.09.005. Epub 2017 Nov 24.

12.

Pyruvate kinase deficiency: novel mutations and a better understanding of the genotype-to-phenotype correlation in Brazilian patients.

Cançado RD.

Rev Bras Hematol Hemoter. 2018 Jan - Mar;40(1):1-2. doi: 10.1016/j.bjhh.2017.08.009. Epub 2017 Dec 6. No abstract available.

13.

Chromosomal aberrations detected by Fluorescence in situ hybridization in 344 Brazilian chronic lymphocytic leukemia patients.

Zorovich MESLDM, Dourado DA, Chauffaille MLLF.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):388-390. doi: 10.1016/j.bjhh.2017.05.008. Epub 2017 Jun 28. No abstract available.

14.

Molecular genetic techniques for gains and losses of genomic material in a case of acute myeloid leukemia.

Santos MFMD, Lara CC, Velloso EDRP.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):385-387. doi: 10.1016/j.bjhh.2017.06.001. Epub 2017 Jul 20. No abstract available.

15.

Acute myeloid leukemia with e1a2 BCR-ABL1 fusion gene: two cases with peculiar molecular and clinical presentations.

da Silva FB, Machado-Neto JA, Koury LCA, Bertini VHLL, Ratis CA, Chauffaille MLLF, Velloso EDRP, Simões BP, Rego EM, Traina F.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):379-384. doi: 10.1016/j.bjhh.2017.07.001. Epub 2017 Aug 3. No abstract available.

16.

Role of daratumumab in transfusion medicine: a must know entity.

Subramaniyan R, Satheshkumar R, Pereira KR.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):375-378. doi: 10.1016/j.bjhh.2017.07.002. Epub 2017 Aug 8. No abstract available.

17.

Osteopetrosis in twin infants mimicking leukemia.

Jain M, Mittal P, Shukla A, Kumar A.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):372-374. doi: 10.1016/j.bjhh.2017.06.002. Epub 2017 Jul 21. No abstract available.

18.

DNA microarray expression profiling of a new t(8;13) AML case allows identification of possible leukemogenic transformation markers.

Pozzo AR, Faria FCC, Carvalho LO, Pinho MB, Maia RC.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):368-371. doi: 10.1016/j.bjhh.2017.06.003. Epub 2017 Jul 22. No abstract available.

19.

Passenger lymphocyte syndrome in liver transplantation.

Brunetta DM, Albuquerque LM, Batista AHM, Santos LHO, Schreen D, Lima CA, Mesquita DFG, Carlos LMB, Garcia JHP.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):364-367. doi: 10.1016/j.bjhh.2017.07.006. Epub 2017 Aug 26. No abstract available.

20.

Primary imatinib failure rescued by dasatinib and maintained by reintroduction of imatinib.

Kumar R, Kapoor R.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):360-363. doi: 10.1016/j.bjhh.2017.06.006. Epub 2017 Jul 26. No abstract available.

Supplemental Content

Loading ...
Support Center